Abstract Search

ea0099p72 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Metabolic and renal benefits of using sodium-glucose cotransporter type 2 inhibitors in patients with type 1 diabetes mellitus and continuous subcutaneous insulin infusion

Perez Lopez Paloma , Torres Torres Beatriz , Delgado Garcia Esther , Gomez Hoyos Emilia , Diaz Soto Gonzalo , de la O Nieto de la Marca Maria , Ortolabuigues Ana , De Luis Roman Daniel

Ntroduction and Aim: The use of sodium-glucose cotransporter type 2 (SGLT-2) inhibitors has importantly improved the management of patients with type 2 diabetes mellitus. The aim of the present study was to evaluate the renal and metabolic effects after one year of SGLT-2 use in a cohort of patients with type 1 diabetes mellitus (T1D) treated with continuous subcutaneous insulin infusion (CSII).Methods: Retrospective observational study in adult patients...

0 shares

Endocrine Abstracts

Metabolic and renal benefits of using sodium-glucose cotransporter type 2 inhibitors in patients with type 1 diabetes mellitus and continuous subcutaneous insulin infusion

BiosciAbstracts